Review
Current data and strategy in glioblastoma multiforme
Affiliations
- PMID: 20108752
- PMCID: PMC3019011
Item in Clipboard
Review
Current data and strategy in glioblastoma multiforme
J Med Life.
2009 Oct-Dec.
Abstract
Glioblastoma multiforme (GBM) or astrocytoma grade IV on WHO classification is the most aggressive and the most frequent of all primary brain tumors. Glioblastoma is multiforme, resistant to therapeutic interventions illustrating the heterogeneity exhibited by this tumor in its every aspect, including clinical presentation, pathology, genetic signature. Current data and treatment strategy in GBM are presented focusing on basic science data and key clinical aspects like surgery, including personal experience; adjuvant modalities: radiotherapy, chemotherapy, but also for experimental approaches. Therapeutic attitude in recurrent GBM is also widely discussed.
Similar articles
-
PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme.J Natl Cancer Inst. 2001 Aug 15;93(16):1246-56. doi: 10.1093/jnci/93.16.1246. J Natl Cancer Inst. 2001. PMID: 11504770
-
Response to erlotinib in recurrent glioblastoma multiforme showing coexpression of EGFRvIII and PTEN.Clin Transl Oncol. 2010 Apr;12(4):310-4. doi: 10.1007/s12094-010-0510-z. Clin Transl Oncol. 2010. PMID: 20462843
-
Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt astrocytoma to glioblastoma.Acta Neuropathol. 2018 Nov;136(5):793-803. doi: 10.1007/s00401-018-1905-0. Epub 2018 Sep 5. Acta Neuropathol. 2018. PMID: 30187121
-
PTEN signaling pathways in glioblastoma.Cancer Biol Ther. 2008 Sep;7(9):1321-5. doi: 10.4161/cbt.7.9.6954. Epub 2008 Sep 8. Cancer Biol Ther. 2008. PMID: 18836294 Review.
-
Immunohistochemical and molecular genetic study on epithelioid glioblastoma: Series of seven cases with review of literature.Pathol Res Pract. 2018 May;214(5):679-685. doi: 10.1016/j.prp.2018.03.019. Epub 2018 Mar 22. Pathol Res Pract. 2018. PMID: 29615337 Review.
Cited by
-
Advances in Brain Tumor Surgery for Glioblastoma in Adults.Brain Sci. 2017 Dec 20;7(12):166. doi: 10.3390/brainsci7120166. Brain Sci. 2017. PMID: 29261148 Free PMC article. Review.
-
Glioma and glioblastoma - how much do we (not) know?Mol Clin Oncol. 2013 Nov;1(6):935-941. doi: 10.3892/mco.2013.172. Epub 2013 Aug 26. Mol Clin Oncol. 2013. PMID: 24649273 Free PMC article. Review.
-
Polymeric Nanoparticles for the Treatment of Malignant Gliomas.Cancers (Basel). 2020 Jan 10;12(1):175. doi: 10.3390/cancers12010175. Cancers (Basel). 2020. PMID: 31936740 Free PMC article. Review.
-
γδ T cells as a potential therapeutic agent for glioblastoma.Front Immunol. 2023 Oct 20;14:1273986. doi: 10.3389/fimmu.2023.1273986. eCollection 2023. Front Immunol. 2023. PMID: 37928546 Free PMC article. Review.
-
Emerging Gene-editing nano-therapeutics for Cancer.Heliyon. 2024 Oct 20;10(21):e39323. doi: 10.1016/j.heliyon.2024.e39323. eCollection 2024 Nov 15. Heliyon. 2024. PMID: 39524822 Free PMC article. Review.
References
-
- Tang Y. In vivo tracking of neural progenitor cell migration to glioblastomas. Hum Gene Ther. 2003;14:1247–1254. - PubMed
-
- Kitange GJ, Templeton KL, Jenkins RB. Recent advances in the molecular genetics of primary gliomas. Curr Opin Oncol. 2003;15:197–203. - PubMed
-
- Dohrmann D, Farwell RJ, Flannery JT. Glioblastoma multiforme in children. J Neurosurg. 1976;44 - PubMed
-
- Inskip PD, Hatch EE. Cellular–telephone use and brain tumors. N Engl J Med. 2001;344:79–86. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical